We have located links that may give you full text access.
JOURNAL ARTICLE
REVIEW
Incidence of postpartum hypertension within 2 years of a pregnancy complicated by preeclampsia: a systematic review and meta-analysis.
BJOG : An International Journal of Obstetrics and Gynaecology 2020 September 28
BACKGROUND: Women with a history of hypertensive disorders of pregnancy (HDP) are at increased long-term risk of cardiovascular disease. However, there has been increasing evidence on the same risks in the months following birth.
OBJECTIVES: This review aims to estimate the incidence of hypertension in the first two years after HDP.
SEARCH STRATEGY: MEDLINE, EMBASE and Cochrane databases were systematically searched in October 2019.
SELECTION CRITERIA: Observational studies comparing hypertension rate following HDP and normotensive pregnancies up to two years.
DATA COLLECTION AND ANALYSIS: A meta-analysis to calculate the odds ratio (OR) with a 95% confidence interval (CI) and a sub-group analysis excluding women with chronic hypertension were performed.
MAIN RESULTS: Hypertension was diagnosed within the first two years following pregnancy in 468/1646 (28.4%) and 584/6395 (9.1%) of the HDP and control groups, respectively (OR=6.28; 95% CI 4.18-9.43; I2 =56%). The risk of hypertension in HDP group was significantly higher in the first six months following delivery (OR=18.33; 95% CI 1.35-249.48; I2 =84%) than at six to twelve months (OR=4.36; 95% CI 2.81-6.76; I2 =56%) or between one to two years postpartum (OR 7.24; 95% CI 4.44-11.80; I2 =9%). A sub-group analysis demonstrated a similar increase in the risk of developing postpartum hypertension after HDP (OR 5.75; 95% CI 3.92-8.44; I2 =49%) and preeclampsia (OR=6.83; 95% CI 4.25-10.96; I2 =53%).
CONCLUSIONS: The augmented risk of hypertension after HDP is highest in the early postpartum period suggesting that diagnosis and targeted interventions to improve maternal cardiovascular health may need to be commenced in the immediate postpartum period.
OBJECTIVES: This review aims to estimate the incidence of hypertension in the first two years after HDP.
SEARCH STRATEGY: MEDLINE, EMBASE and Cochrane databases were systematically searched in October 2019.
SELECTION CRITERIA: Observational studies comparing hypertension rate following HDP and normotensive pregnancies up to two years.
DATA COLLECTION AND ANALYSIS: A meta-analysis to calculate the odds ratio (OR) with a 95% confidence interval (CI) and a sub-group analysis excluding women with chronic hypertension were performed.
MAIN RESULTS: Hypertension was diagnosed within the first two years following pregnancy in 468/1646 (28.4%) and 584/6395 (9.1%) of the HDP and control groups, respectively (OR=6.28; 95% CI 4.18-9.43; I2 =56%). The risk of hypertension in HDP group was significantly higher in the first six months following delivery (OR=18.33; 95% CI 1.35-249.48; I2 =84%) than at six to twelve months (OR=4.36; 95% CI 2.81-6.76; I2 =56%) or between one to two years postpartum (OR 7.24; 95% CI 4.44-11.80; I2 =9%). A sub-group analysis demonstrated a similar increase in the risk of developing postpartum hypertension after HDP (OR 5.75; 95% CI 3.92-8.44; I2 =49%) and preeclampsia (OR=6.83; 95% CI 4.25-10.96; I2 =53%).
CONCLUSIONS: The augmented risk of hypertension after HDP is highest in the early postpartum period suggesting that diagnosis and targeted interventions to improve maternal cardiovascular health may need to be commenced in the immediate postpartum period.
Full text links
Related Resources
Trending Papers
Heart failure with preserved ejection fraction: diagnosis, risk assessment, and treatment.Clinical Research in Cardiology : Official Journal of the German Cardiac Society 2024 April 12
Proximal versus distal diuretics in congestive heart failure.Nephrology, Dialysis, Transplantation 2024 Februrary 30
Efficacy and safety of pharmacotherapy in chronic insomnia: A review of clinical guidelines and case reports.Mental Health Clinician 2023 October
World Health Organization and International Consensus Classification of eosinophilic disorders: 2024 update on diagnosis, risk stratification, and management.American Journal of Hematology 2024 March 30
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app